Hydrogen Therapy Helps Repair Damaged Cartilage in Arthritis Models

Authors
Journal
Cell Stem Cell
Year
DOI
10.1016/j.stem.2026.03.002
Study Type
Cell Culture
Outcome
Positive
Peer Reviewed
Yes
Country
China
Health Condition
Osteoarthritis
Body System
Musculoskeletal

TL;DR

A sustained hydrogen-releasing hydrogel improved stem cell survival and promoted cartilage repair in osteoarthritis models.

Key Finding

A hydrogen-releasing hydrogel containing cartilage cells successfully preserved cell viability in osteoarthritic conditions and promoted rapid cartilage repair in animal models, reversing osteoarthritic progression within 6 months.

Summary

Researchers developed a new treatment for osteoarthritis that combines cartilage-repairing cells with a special material that releases hydrogen gas over time. In laboratory and animal studies, this combination preserved the health and function of the transplanted cells in the damaged, inflammatory environment of arthritic joints, and successfully repaired cartilage defects in rodents and sheep within 6 months.

Practical Takeaway

This early-stage research in animals suggests that sustained hydrogen delivery may help protect transplanted cells used in cartilage repair therapies. However, this work has not been tested in humans yet, and much more research is needed before any clinical applications. The findings are promising for future cell-based osteoarthritis treatments, but remain experimental.

Abstract

The inflammatory pathological microenvironment of osteoarthritis (OA) degrades the cell state and function of stem cell-derived grafts and presents a major obstacle to developing effective cell therapies. Here, we show that the viability and hyaline cartilage phenotype of bone marrow-derived mesenchymal stem cell (BMSC)-derived chondrocyte microspheroids (CMSs) can be efficiently preserved during spheroidization with persistent H2 supply and in an OA microenvironment. We therefore developed TiSi2 nanosheets (TSN) that hydrolytically generate a sustained (> 2 months) high dose of H2 and construct a H2-releasing hydrogel transplant (TSN/CMS-Gel) by encapsulating TSN and CMSs within a photo-crosslinking hydrogel (Gel). Transplantation of TSN/CMS-Gel achieves a strong survival of chondrocytes in a rodent OA model and promotes the rapid and efficient repair of sheep osteoarthritic critical-size cartilage defects, as well as the reversal of osteoarthritic progression within 6 months. The proposed strategy of locally sustaining H2-mediated preservation of transplanted chondrocytes in the pathological microenvironment opens new opportunities to enhance cell transplantation outcomes.